Delivery Order SPE2DE24D0013-SPE2D626F7966
- Not listed
- The Defense Logistics Agency awarded a $13.6K delivery order to Cepheid Inc. for the Xpert Xpress COVID-19/Flu/RSV molecular diagnostic kit on September 25, 2025. This firm fixed-price contract, with performance in Sunnyvale, California, represents a single delivery order with no set-aside designation. Cepheid, a leading manufacturer of molecular diagnostic solutions, supplies rapid point-of-care testing kits designed to detect multiple respiratory pathogens simultaneously, supporting the...
- The Defense Logistics Agency Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on July 22, 2025, for the XpertXpress COVID-19, Influenza, RSV, and Molecular Biology test kit. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will perform the work at its California facility. This delivery order carries no set-aside designation and represents a continuation of Cepheid's long-standing relationship supplying diagnostic...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- The U.S. Department of Defense's Medical Supply Chain awarded a $13.6K firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer, likely supporting COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities across military healthcare systems. The award carries no...
- This delivery order, valued at $40,800, was awarded to Cepheid Inc. on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the provision of molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 2, 2025. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F7966Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on October 31, 2025, for the XpertXpress COVID-19, Influenza, and RSV molecular diagnostic kit. The contract, which carries no set-aside designation, is scheduled for completion by November 7, 2025, with performance to take place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the federal government's reliance on Cepheid's rapid molecular diagnostic testing capabilities, which have become essential to military and defense healthcare operations. Cepheid has established itself as a primary federal supplier of molecular diagnostics across multiple defense and civilian healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's GeneXpert diagnostic platform and associated molecular testing solutions provide rapid detection of respiratory pathogens and infectious diseases critical to medical readiness and patient care. The current award demonstrates the Defense Logistics Agency's continued procurement of Cepheid's respiratory pathogen detection reagents and test kits to support diagnostic capabilities across military medical facilities and supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 10/31/25 |